Frankfurt - Delayed Quote • EUR Sanofi (SNW.F) Follow Compare 95.10 -0.96 (-1.00%) As of 5:03:53 PM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for SNW.F 1D 5D 0.56% 1M 5.43% 3M -5.01% 6M 1.08% YTD 1.61% 1Y -0.90% 5Y 2.66% All 129.31% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: SNW.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma IGM Biosciences downgraded to Hold from Buy at Jefferies SNY's Subcutaneous Sarclisa Outperforms IV Formulation in Cancer Study Sanofi reports positive results from trial of multiple myeloma drug candidate Sanofi's Blood Cancer Drug's New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma Sanofi taps Alloy Therapeutics for CNS antisense drug development Third Rock-backed Maze Therapeutics reveals profit in US IPO filing Denali's ALS Study Fails to Meet Primary and Secondary Endpoints Sanofi Down 10% in 3 Months: How Should You Play the Stock? Drugmakers to raise US prices on over 250 medicines starting Jan. 1 Related Tickers BAYA.BE Bayer AG 5.0000 +0.40% JNJd.XC 600436.SS PIENTZEHUANG 205.00 +0.29% GS71.DE GSK plc 16.01 -1.42% NOVNEE.SW Novartis AG 91.08 -0.32% COPNz.XC ZEG.DE AstraZeneca PLC 129.25 -1.52% JNJ.HM Johnson & Johnson 140.34 +0.52% BAYZF Bayer Aktiengesellschaft 20.73 +1.92% PFE.DU Pfizer Inc 25.86 -1.77%